Study of baxdrostat for primary aldosteronism
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new drug called baxdrostat for people with primary aldosteronism, a condition where the adrenal glands make too much aldosterone hormone, often causing high blood pressure. The goal is to see if baxdrostat helps control blood pressure and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have primary aldosteronism as defined by standard medical guidelines.
- You must be able to stop taking certain blood pressure medicines (called MRAs or potassium-sparing diuretics) if you are currently taking them.
- Your kidney function must be good enough (eGFR at least 45).
- Your blood potassium level must be between 3.0 and 5.0 mmol/L at the start.
- Your blood pressure must be in a specific range: sitting systolic between 135 and 170 mmHg, and diastolic no higher than 105 mmHg.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new pill called baxdrostat can help reduce the activity of aldosterone-producing nodules in the adrenal glands. It uses special imaging to see if the treatment shrinks or changes these nodules, which might help control blood pressure better.
This trial tests a new medicine, SAL0140, for people with primary aldosteronism, a condition where the adrenal glands make too much aldosterone, causing high blood pressure. The study aims to see if the drug can lower blood pressure and improve health.
This trial tests a new medicine called baxdrostat for people whose blood pressure stays high even when they take two or more medicines. It will be added to your current blood pressure pills to see if it helps lower your blood pressure more.
This study tests a new drug called QLS1410 for people with primary aldosteronism, a condition that causes high blood pressure due to too much aldosterone. The drug aims to lower blood pressure and improve health, potentially offering a new treatment option.
This study tests whether adjusting a type of blood pressure medication (called a mineralocorticoid receptor antagonist) based on renin levels is safe and helpful for people with primary aldosteronism. It aims to find a better way to manage the condition.
This trial studies whether a medicine that blocks aldosterone (called an MRA) can improve cardiovascular outcomes in people with high aldosterone levels and high blood pressure. You may be asked to take the study medicine and have blood pressure, heart, and lab tests monitored over time.
Hear when a new Primary Hyperaldosteronism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.